The disclosure is made pursuant to Regulation 30 and Regulation 46 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirement) Regulations, 2015.
The subject is the audio recording of the Earnings Call on the Audited Standalone and Consolidated Financial Results for the quarter and year ended March 31, 2026.
The earnings call was held on Friday, May 29, 2026.
Company and Signatory
The company is Gaudium IVF and Women Health Limited (Formerly known as Gaudium IVF and Women Health Private Limited).
The disclosure is signed digitally by Naveen Kumar, Company Secretary and Compliance Officer (Membership No: A69788), on May 29, 2026, at 15:52:53 IST.
